vision changes on tirzepatide Potential rare complications tied to blockbuster GLP-1s Semaglutide or Tirzepatide and Optic
Description
Cureus provides an equitable, efficient publishing and peer reviewing experience without sacrificing publication times
Users with significant weight loss goals, metabolic syndrome, or type 2 diabetes that has not responded adequately to GLP-1 monotherapy may benefit from the additional GIP pathway activation
Visit our Medication Safety Information
Great product It has helped me lose weight and not had any negative side effects so far
This is one of the fundamental reasons behind aging, disease and cellular decline
